Funder: Pfizer Inc.
Due Dates: May 4, 2026 (Full proposal submission)
Funding Amounts: Up to $120,000 USD per project; up to $180,000 USD if third-party lab/transport required; project duration up to 3 years
Summary: Funds research on pneumococcal disease serotype distribution and antimicrobial resistance in pediatric and adult populations in Türkiye using advanced surveillance and diagnostic methods.
Key Information: Principal Investigator and institution must be based in Türkiye; organizations only (not individuals/practice groups).